Gritstone Bio Stock (NASDAQ: GRTS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 2.15K / 1.26M |
Day Range | - - - |
52 Wk Range | 0.42 - 3.33 |
Market Cap | $72.05M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 64 |
Short Interest | 5.99% |
Days to Cover | 7.89 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Gritstone Bio (NASDAQ:GRTS) through any online brokerage.
Other companies in Gritstone Bio’s space includes: Renovaro (NASDAQ:RENB), Serina Therapeutics (AMEX:SER), Cellectar Biosciences (NASDAQ:CLRB), Connect Biopharma Hldgs (NASDAQ:CNTB) and OS Therapies (AMEX:OSTX).
Gritstone Bio has a consensus price target of $4.20.
The stock price for Gritstone Bio (NASDAQ: GRTS) is $0.61 last updated September 23, 2024 at 6:12 AM EDT.
There are no upcoming dividends for Gritstone Bio.
Gritstone Bio’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Gritstone Bio.
Gritstone Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.